CAMBRIDGE, England and BOSTON, Dec. 7, 2017 /PRNewswire/ -- Natural Language Processing (NLP) text analytics provider, Linguamatics, today announced that the company has extended its position as a leading provider of NLP text-mining solutions for healthcare and the life sciences with the introduction of multiple innovations in 2017.

Linguamatics' mission is to turn unstructured patient data into actionable insights that support population health, precision medicine and clinical research. Linguamatics is the world leader in deploying innovative health science focused natural language processing solutions for high-value knowledge discovery, information extraction and decision support. Linguamatics I2E is used by leading hospitals, the FDA, premier academic institutions and 17 of the top 20 global pharmaceutical companies.

New capabilities include custom search interfaces using I2E web portals, providing much larger, wide-ranging user communities with web access to the benefits of deep NLP capabilities. Programmatic use of I2E is enhanced by I2E AMP, which delivers high-throughput, fault tolerant workflow management for real-time document processing. AMP is deployed at multiple customer sites in a variety of workflows, including safety and regulatory affairs.

"Over the last year, more customers have taken advantage of the capabilities of I2E with AMP for ETL (Extract, Transform, and Load) use cases," said Linguamatics Chief Business Development Officer Phil Hastings. "It's exciting to see the numerous ways customers are benefitting from the ability to transform their unstructured data to a structured format that can be loaded into data warehouses or data lakes, or consumed by downstream applications for broader access and decision support."

This year, Linguamatics released two major updates to the I2E platform, adding features that included enhanced results management options, and advances in core capabilities including spelling and OCR correction. In addition, Linguamatics launched its Community site for Linguamatics I2E customers and partners - including a new Developer site for Community members with programming backgrounds who want to learn more about I2E's technical features and network with other users to share best practices.

Over the past year, Linguamatics customers have expanded their use of I2E to mine EHR data for predictive risk models and quality measurement, and for Real World Evidence analysis of outcomes and patient characteristics. Based on the success of these efforts, Frost and Sullivan recognized Linguamatics with an excellence in best practices award for "Big Data Text Analytics for Healthcare".

At the 2017 Linguamatics Text Mining Summits, customers shared details about the innovative ways they are leveraging I2E. Client representatives from AstraZeneca, Cancer Research UK, Cell Signaling Technology, Huntsman Cancer Institute, Kaiser Permanente, Mundipharma, Penn Medicine, Pfizer, Roche and Sanofi discussed specific I2E use cases, from early drug discovery to clinical applications. Speakers also shared how they've successfully escalated their use of artificial intelligence machine-learning technologies, thanks to I2E's ability to normalize unstructured data to enhance predictive models.

"Linguamatics has made outstanding progress this year in providing the benefits of text mining to a wider audience," said Linguamatics Chief Technology Officer, David Milward. "Our new web portal framework is part of an ongoing strategy to broaden access to powerful NLP capabilities. The development of AMP for highly scalable and fault-tolerant document processing, along with improved SDKs, backed up by the launch of our Community and Developer sites, is increasing the programmatic use of I2E, enabling NLP to underpin multiple applications in enterprise data analysis such as quality checking, extraction of meta-data and detailed relationship extraction."

About Linguamatics

Linguamatics transforms unstructured big data into big insights to advance human health and wellbeing. A world leader in deploying innovative natural language processing (NLP)-based text mining for high-value knowledge discovery and decision support, Linguamatics' solutions are used by top commercial, academic and government organizations, including 18 of the top 20 global pharmaceutical companies, the US Food and Drug Administration (FDA) and leading US healthcare organizations.

Linguamatics I2E is used to mine a wide variety of text resources, such as scientific literature, patents, Electronic Health Records (EHRs), clinical trials data, news feeds, social media and proprietary content. I2E can be deployed as an in-house enterprise system, or as Software-as-a-Service (SaaS) on the cloud. For more information, visit linguamatics.com and follow @Linguamatics on Twitter.

Linguamatics Media contact:
Michelle Ronan Noteboom, Sr. Account Director 
Amendola Communications
+ 1 512.426.2870
mnoteboom@acmarketingpr.com

View original content with multimedia:http://www.prnewswire.com/news-releases/linguamatics-extends-text-analytics-leadership-in-2017-300567873.html

SOURCE Linguamatics

Copyright 2017 PR Newswire